YB-1113

N/A

Report date: 2025/08/19 20:00:08

Base Information

Drug NameYB-1113
Drug Alias NameHuman umbilical cord tissue-derived mesenchymal stem cells (hUC-MSC)hUC-MSCYB-1113
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapy
Mechanisms of ActionStem cell replacements
TargetsNot applicable
Therapy Area/IndicationsPrimary Ovarian Insufficiency
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesBright Cell Inc
China Registration ClassN/A

Develop Information

Active CompaniesBright Cell Inc
Inactive CompaniesN/A
Active IndicationsPrimary Ovarian Insufficiency
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A